
1. mol ther oncolytics. 2016 dec 10;4:18-30. doi: 10.1016/j.omto.2016.11.003.
ecollection 2017 mar 17.

oncolytic group b adenovirus enadenotucirev mediates non-apoptotic cell death
with membrane disruption release inflammatory mediators.

dyer a(1), di y(1), calderon h(2), illingworth s(2), kueberuwa g(1), tedcastle
a(1), jakeman p(1), chia sl(1), brown a(2), silva ma(3), barlow d(1), beadle
j(2), hermiston t(4), ferguson dj(5), champion b(2), fisher kd(1), seymour lw(1).

author information: 
(1)department oncology, university oxford, oxford ox3 7dq, uk.
(2)psioxus therapeutics, ltd., milton park, abingdon ox14 4sd, uk.
(3)department surgical sciences, university oxford, oxford ox3 9du, uk.
(4)bayer healthcare, 455 mission bay blvd. s., san francisco, ca 94158, usa.
(5)nuffield department clinical laboratory science, university oxford,
oxford ox3 9du, uk.

enadenotucirev (enad) chimeric group b adenovirus isolated bioselection
from library adenovirus serotypes. replicates selectively kills 
diverse range carcinoma cells, shows effective anticancer activity in
preclinical systems, currently undergoing phase i/ii clinical trials. enad
kills cells quickly type 5 adenovirus, speed cytotoxicity is
dose dependent. enad death pathway involve p53, predominantly
caspase independent, appears involve rapid fall cellular atp.
infected cells show early loss membrane integrity; increased exposure
of calreticulin; extracellular release atp, hsp70, hmgb1; influx of
calcium. virus also causes obvious single membrane blister reminiscent 
ischemic cell death oncosis. human tumor biopsies maintained ex vivo
culture, enad mediated release pro-inflammatory mediators tnf-α, il-6,
and hmgb1. accordance this, enad-infected tumor cells showed potent
stimulation dendritic cells cd4+ t cells mixed tumor-leukocyte
reaction in vitro. whereas many viruses evolved efficient propagation
with minimal inflammation, bioselection enad rapid killing yielded a
virus short life cycle combines potent cytotoxicity a
proinflammatory mechanism cell death.

doi: 10.1016/j.omto.2016.11.003 
pmcid: pmc5363721
pmid: 28345021 

